The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Active Advocacy in the Sunshine State: Florida Society Presses for Legislative Changes to Protect Patient Access to Medications

Active Advocacy in the Sunshine State: Florida Society Presses for Legislative Changes to Protect Patient Access to Medications

May 17, 2017 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

At their state capitol in Tallahassee on March 28, seven board members of the Florida Society of Rheumatology (FSR) lobbied to support legislation regarding prior authorization, step therapy and non-medical switching. They also educated lawmakers about rheumatic diseases and how access to the right therapy may dramatically improve patients’ lives.

You Might Also Like
  • Reap the Rewards of State Society Involvement
  • Florida Society of Rheumatology in the Spotlight
  • State Legislative Update: Setting the Stage for 2020 & Beyond
Also By This Author
  • 2014 ACR/ARHP Annual Meeting: New Directions for Gout

“We talked about the problems encountered when step therapy is not appropriate for a patient and followed this with case studies. We talked about our patients and what kind of diseases they have. We explained that before biologic drugs were available, about half of rheumatoid arthritis patients were disabled within 10 years,” says FSR President Robert W. Levin, MD, a practicing rheumatologist in Clearwater, Fla. “We told them what the pharmacy benefit managers [PBMs] have done to usurp our primary role to guide our patients to the best therapy for their diseases. The current rebate system has allowed the PBMs to essentially practice medicine without a license.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

2 Key Issues
In Florida, bills must pass simultaneously in both houses of the legislature, says Dr. Levin. The FSR supports the Health Insurance Authorization bills (HB 877/SB 530), which would add transparency to prior authorization and step therapy processes that control fail-first protocols and require insurers to give policy holders and providers advance notice on protocol changes. “It would give us the option to sidestep step therapy when it’s not appropriate for a patient,” says Dr. Levin.

They also lobbied for the Consumer Protection from Nonmedical Changes to Prescription Drug Formularies bills (HB 95/SB 182), which would restrict health benefit plans from changing formularies in the middle of contracts, as well as restrict the subtraction of drugs from formularies. “This bill would force the insurer to keep the same drugs on the formulary for the whole insurance year.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A Political Force
“Politically, we want to become a force to shape our own legislative agenda in Florida. It’s important to drive legislation on our issues as rheumatologists,” Dr. Levin says. “We learned the hard way that we needed to have feet on the ground at the legislature. We’ve worked to address bad language in bills and to have a seat at the table when legislation is being crafted. It’s an ongoing process. We want to improve what we are able to do for our patients and reduce the hassles of practicing medicine.”

Upcoming FSR Annual Meeting
The FSR will holds its annual meeting on June 22–25 in Orlando. More than 200 rheumatologists and 350 total attendees are expected, says Dr. Levin. Attendees can earn up to 14 continuing medical education hours, and topics include integrative rheumatology, evidence-based vasculitis treatment, as well as tips for success in the new Merit-Based Incentive Payment Systems (MIPS). There is also a track for office managers.

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy, Professional Topics Tagged With: Advocacy, Consumer Protection from Nonmedical Changes to Prescription Drug Formularies bills, Florida Society of Rheumatology, Health Insurance Authorization bills, non-medical switching, prior authorization, step therapy

You Might Also Like:
  • Reap the Rewards of State Society Involvement
  • Florida Society of Rheumatology in the Spotlight
  • State Legislative Update: Setting the Stage for 2020 & Beyond
  • ACR Affiliate Society Council Spotlights State Efforts for Advocacy

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.